Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Flávia de Lima Osório(Conselho Nacional de Desenvolvimento Científico e Tecnológico), Jaime E. C. Hallak(Universidade de Ribeirão Preto), Jordi Riba(Universitat Autònoma de Barcelona), José Alexandre S. Crippa(Universidade de Ribeirão Preto), Dráulio Barros de Araújo(Universidade Federal do Rio Grande do Norte), Lauro Wichert‐Ana(Universidade de Ribeirão Preto), Ligia Ribeiro Horta de Macedo(Hospital Universitário da Universidade de São Paulo), João Paulo Maia‐de‐Oliveira(Universidade Federal do Rio Grande do Norte), Rafael G. dos Santos(Clinics Hospital of Ribeirão Preto), Rafael Faria Sanches(Universidade de Ribeirão Preto)
Cited by 484
Related Papers
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|Journal of Psychopharmacology|2010|530
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression
|Journal of Clinical Psychopharmacology|2015|465
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
|Brazilian Journal of Medical and Biological Research|2006|410